Is there a future for biologics in COPD and asthma?

Sponsored by A. Menarini Pty Ltd

Biologics can achieve clinically important risk reductions in eosinophilic airway disease – as long as you give them to the right patients with the right pathology and look at the right outcome measures, an international expert says. Speaking at a respiratory forum in Melbourne Professor Ian Pavord, a consultant respiratory physician at the University of ...

Already a member?

Login to keep reading.

© 2021 the limbic